Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,299	1,430	1,497	2,843	1,685	463
Market Cap Growth	28.82%	-4.52%	-47.33%	68.68%	263.88%	-3.26%
Enterprise Value	304	671	488	2,344	972	275
PE Ratio	-	-4.66	-5.61	53.64	-13.70	-5.47
PS Ratio	5.48	12.22	13.37	7.42	21.61	30.88
PB Ratio	1.84	3.10	2.28	3.38	3.36	2.83
P/FCF Ratio	-7.30	-4.33	3.47	-10.08	15.61	-6.14
P/OCF Ratio	-8.17	-4.67	3.42	-11.11	15.18	-6.30
EV/Sales Ratio	1.28	5.73	4.36	6.12	12.46	18.31
EV/EBITDA Ratio	-3.43	-2.35	-1.94	37.81	-8.17	-3.39
EV/EBIT Ratio	-3.17	-2.23	-1.84	42.62	-7.90	-3.24
EV/FCF Ratio	-3.07	-2.03	1.13	-8.31	9.00	-3.64
Debt / Equity Ratio	-	-	-	-	0.03	-
Debt / EBITDA Ratio	-	-	-	-	-0.13	-
Debt / FCF Ratio	-	-	-	-	0.14	-
Quick Ratio	5.05	4.33	5.43	7.49	6.00	8.31
Current Ratio	5.22	4.52	5.53	7.60	6.05	8.49
Asset Turnover	0.20	0.10	0.08	0.36	0.14	0.07
Return on Equity (ROE)	-41.00%	-57.20%	-36.80%	8.00%	-30.40%	-44.60%
Return on Assets (ROA)	-19.30%	-25.80%	-18.50%	5.00%	-22.00%	-36.90%
Return on Capital (ROIC)	-38.19%	-73.59%	-42.62%	6.18%	-23.96%	-54.14%
Earnings Yield	-17.79%	-21.47%	-17.83%	1.86%	-7.30%	-18.29%
FCF Yield	-18.09%	-23.08%	28.85%	-9.92%	6.41%	-16.28%
Buyback Yield / Dilution	-18.08%	-2.78%	2.70%	-35.04%	-25.04%	-26.60%
Total Shareholder Return	-18.08%	-2.78%	2.70%	-35.04%	-25.04%	-26.60%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).